Table 2 Immuohistochemical analysis of the BMI1 and PIM2 according to the intensity and the extent of staining in the bone marrow samples of DLBCL patients.

From: Lymphocyte to monocyte ratio predicts survival and is epigenetically linked to miR-222-3p and miR-26b-5p in diffuse large B cell lymphoma

Marker

BMI1

PIM2

 + VE

27 (67.5%)

31 (77.5%)

Mild (Less than 20%) ( +) 14

Moderate (20–70%) (+ +) 11

High (70–100%) (+ + +) 2

Mild (6–25%) ( +) 22

Moderate (26–75%) (+ +) 7

High (76–100%) (+ + +) 2

− VE

13 (32.5%)

9 (22.5%)

  1. B lymphoma Mo-MLV insertion region 1 homolog (BMI1), Prodigal insertion site in Maloney murine leukemia virus (PIM), Diffuse Large B Cell Lymphoma (DLBCL).